AZN icon

AstraZeneca

188.10 USD
-4.93
2.55%
At close Updated Feb 9, 3:59 PM EST
1 day
-2.55%
5 days
0.26%
1 month
98.73%
3 months
115.02%
6 months
153.95%
Year to date
105.42%
1 year
158.88%
5 years
273.14%
10 years
557.92%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,554 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™